Barclays PLC Albireo Pharma, Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$18.01 - $23.78 $74,921 - $98,924
4,160 Added 207.69%
6,163 $134,000
Q3 2022

Nov 03, 2022
BUY
$16.32 - $26.37 $18,572 - $30,009
1,138 Added 131.56%
2,003 $39,000
Q2 2022

Aug 12, 2022
SELL
$18.54 - $37.29 $36,190 - $72,790
-1,952 Reduced 69.29%
865 $17,000
Q1 2022

May 16, 2022
SELL
$23.94 - $33.74 $422,852 - $595,949
-17,663 Reduced 86.25%
2,817 $84,000
Q4 2021

Feb 14, 2022
BUY
$21.19 - $31.29 $286,552 - $423,134
13,523 Added 194.38%
20,480 $477,000
Q3 2021

Nov 09, 2021
BUY
$27.36 - $35.98 $125,828 - $165,472
4,599 Added 195.04%
6,957 $217,000
Q2 2021

Aug 13, 2021
SELL
$28.9 - $36.87 $454,076 - $579,301
-15,712 Reduced 86.95%
2,358 $83,000
Q1 2021

May 13, 2021
BUY
$32.03 - $42.85 $278,436 - $372,495
8,693 Added 92.71%
18,070 $637,000
Q4 2020

Feb 11, 2021
SELL
$31.56 - $42.16 $20,135 - $26,898
-638 Reduced 6.37%
9,377 $352,000
Q3 2020

Nov 12, 2020
BUY
$23.19 - $41.61 $62,589 - $112,305
2,699 Added 36.89%
10,015 $334,000
Q2 2020

Aug 12, 2020
BUY
$14.82 - $29.92 $46,683 - $94,248
3,150 Added 75.61%
7,316 $195,000
Q1 2020

May 13, 2020
SELL
$11.67 - $27.23 $78,410 - $182,958
-6,719 Reduced 61.73%
4,166 $68,000
Q4 2019

Feb 10, 2020
BUY
$16.92 - $28.96 $93,415 - $159,888
5,521 Added 102.93%
10,885 $277,000
Q3 2019

Nov 14, 2019
SELL
$20.0 - $31.88 $25,880 - $41,252
-1,294 Reduced 19.44%
5,364 $107,000
Q2 2019

Aug 14, 2019
BUY
$30.67 - $37.86 $122,127 - $150,758
3,982 Added 148.8%
6,658 $215,000
Q1 2019

May 15, 2019
BUY
$22.22 - $32.21 $56,061 - $81,265
2,523 Added 1649.02%
2,676 $86,000
Q4 2018

Feb 14, 2019
SELL
$20.9 - $32.57 $70,537 - $109,923
-3,375 Reduced 95.66%
153 $4,000
Q3 2018

Nov 14, 2018
BUY
$29.29 - $36.87 $83,798 - $105,485
2,861 Added 428.94%
3,528 $117,000
Q2 2018

Aug 14, 2018
SELL
$28.9 - $37.31 $151,031 - $194,982
-5,226 Reduced 88.68%
667 $23,000
Q1 2018

May 15, 2018
SELL
$26.78 - $39.35 $21,611 - $31,755
-807 Reduced 12.04%
5,893 $192,000
Q4 2017

Feb 14, 2018
BUY
$21.56 - $28.14 $144,452 - $188,538
6,700
6,700 $172,000

Others Institutions Holding ALBO

# of Institutions
4
Shares Held
865
Call Options Held
0
Put Options Held
0
View Full List

About ALBIREO PHARMA, INC.

ALBO Quotes by TradingView
  • Ticker ALBO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,612,500
  • Description
  • Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...
More about ALBO
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email